Cargando…
Clinical Response to Anti-CD47 Immunotherapy Is Associated with Rapid Reduction of Exhausted Bystander CD4(+) BTLA(+) T Cells in Tumor Microenvironment of Mycosis Fungoides
SIMPLE SUMMARY: The identification of the events that accompany cancer progression is essential for developing new therapies. We have used mycosis fungoides, the most common type of cutaneous lymphoma, as a model for our study. We have shown that cancer progression is accompanied by the expansion of...
Autores principales: | Jiang, Tony T., Kruglov, Oleg, Lin, Gloria H. Y., Minic, Angela, Jordan, Kimberly, Uger, Robert A., Wong, Mark, Shou, Yaping, Akilov, Oleg E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656720/ https://www.ncbi.nlm.nih.gov/pubmed/34885092 http://dx.doi.org/10.3390/cancers13235982 |
Ejemplares similares
-
Romidepsin Controls Chronic Lymphocytic Leukemia in a Patient with Mycosis Fungoides
por: Lemchak, David. M., et al.
Publicado: (2016) -
What Does the Future Hold for Biomarkers of Response to Extracorporeal Photopheresis for Mycosis Fungoides and Sézary Syndrome?
por: Akilov, Oleg E.
Publicado: (2023) -
Targeting the CD47-SIRPα Axis: Present Therapies and the Future for Cutaneous T-cell Lymphoma
por: Xiao, Amy, et al.
Publicado: (2022) -
CD8-positive Mycosis Fungoides Masquerading as Pyoderma Gangrenosum
por: Saha, Maitrayee, et al.
Publicado: (2016) -
CD8(+) mycosis fungoides: a wolf in sheep's clothing?
por: Jonak, C
Publicado: (2019)